SAROJA PHARMA INDUS IND L
Latest filings
- Statutory auditor resigns before five-year term ends · Management Changes
- Routine filing of demat-remat compliance certificate for Q2 FY27 · Compliance
- Whole-time Director Ravindra Salaskar resigns, continues as CFO · Management Changes
Snapshot
What the business is, and whether it's a good one at a fair price.
A listed company listed on NSE.
Scorecard
Measured from the filed financials · as of FY26 — not investment advice
Strengths
Concerns
Nothing flagged in the filed numbers.Charts
How has the market priced it — with filings on the timeline?
SAROJA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from SAROJA PHARMA INDUS IND L's filed financials and exchange disclosures
What does SAROJA PHARMA INDUS IND L do?
SAROJA PHARMA INDUS IND L is listed on NSE, trading under the symbol SAROJA.
How much does the SAROJA PHARMA INDUS IND L share price move in a day?
On a typical session SAROJA PHARMA INDUS IND L moves 4.03% — that is the median absolute close-to-close move across its last 103 trading days. MarketPing measures each filing's price reaction against it.
Where can I track SAROJA PHARMA INDUS IND L's announcements?
Every NSE and BSE filing by SAROJA PHARMA INDUS IND L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.